| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/01/2011 | WO2011104025A1 Assays and kits for serotyping pseudomonas aeruginosa and oligonucleotide sequences useful in such methods and kits |
| 09/01/2011 | WO2011104023A1 Genetic marker for the diagnosis of dementia with lewy bodies |
| 09/01/2011 | WO2011103770A1 Kit for quantitative detection of braf mutation |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | WO2011084426A3 Methods and compositions for inhibiting secreted aspartic proteases and fungal infection and disease |
| 09/01/2011 | WO2011070333A3 Probes with multiple mass-tagged oligomers |
| 09/01/2011 | WO2011061373A8 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment |
| 09/01/2011 | WO2011053907A3 Human omental mesothelial cells, methods of isolation and uses thereof |
| 09/01/2011 | WO2010147372A9 Primer and probe for detecting malaria plasmodium and detection method using same |
| 09/01/2011 | US20110214200 Yield traits for maize |
| 09/01/2011 | US20110214199 Genes and uses for plant enhancement |
| 09/01/2011 | US20110214196 Development of herbicide-resistant grass species |
| 09/01/2011 | US20110214195 Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110214193 Biomarker for microdomain disease |
| 09/01/2011 | US20110214191 Method for the identification of genes involved in neurodegenerative processes |
| 09/01/2011 | US20110214189 G protein coupled receptors and uses thereof |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213137 Isotopically-labeled glycans |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213015 Oligonucleotidic sequences able to silence the expression of the cyclin d1-trop2 chimera and uses thereof in medical field |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213010 Methods and compositions for the treatment of huntington's disease |
| 09/01/2011 | US20110213009 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 09/01/2011 | US20110213007 MicroRNAs and uses thereof |
| 09/01/2011 | US20110213005 Methods for treating viral infections |
| 09/01/2011 | US20110212996 Method to predict response to pharmacological chaperone treatment of diseases |
| 09/01/2011 | US20110212991 Diagnostic Test for Susceptibility to B-RAF Kinase Inhibitors |
| 09/01/2011 | US20110212981 Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression |
| 09/01/2011 | US20110212979 Predictive marker for egfr inhibitor treatment |
| 09/01/2011 | US20110212974 Method for identifying compounds useful for treating and/or preventing disease-associated bone loss |
| 09/01/2011 | US20110212911 Transcription factor inhibitors and related compositions, formulations and methods |
| 09/01/2011 | US20110212857 Multiplexed Assay Using Encoded Solid Support Matrices |
| 09/01/2011 | US20110212855 Genetic Variants Predictive of Cancer Risk |
| 09/01/2011 | US20110212854 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| 09/01/2011 | US20110212853 Novel diagnostic method |
| 09/01/2011 | US20110212852 Compositions and methods to detect atopobium vaginae nucleic acid |
| 09/01/2011 | US20110212851 Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
| 09/01/2011 | US20110212850 Using phylogenetic probes for quantification of stable isotope labeling and microbial community analysis |
| 09/01/2011 | US20110212849 Biomarkers for predicting the development of chronic autoimmune diseases |
| 09/01/2011 | US20110212847 Compositions and methods relating to monitoring alcohol consumption and alcohol abuse |
| 09/01/2011 | US20110212846 Methods and compositions for universal detection of nucleic acids |
| 09/01/2011 | US20110212845 Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors |
| 09/01/2011 | US20110212510 Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor |
| 09/01/2011 | US20110212485 System, method and device for tissue-based diagnosis |
| 09/01/2011 | US20110212484 In Vitro Model of Focal Ischemia |
| 09/01/2011 | US20110212483 Methods and Kits for the Diagnosis of RyR1-Related Diseases |
| 09/01/2011 | US20110212482 Methods and devices for sample collection, treatment and dispensing |
| 09/01/2011 | US20110212481 Assays and methods for fusing cell aggregates to form proto-tissues |
| 09/01/2011 | US20110212480 Use of primary human cardiomyocytes |
| 09/01/2011 | US20110212479 Measurement of sequestered carbon |
| 09/01/2011 | US20110212478 Catheter |
| 09/01/2011 | US20110212477 Lipoprotein-associated markers for cardiovascular disease |
| 09/01/2011 | US20110212476 Genetically engineered g-alpha proteins and uses thereof |
| 09/01/2011 | US20110212475 Fluorescently Or Spin-Labeled Kinases For Rapid Screening And Identification Of Novel Kinase Inhibitor Scaffolds |
| 09/01/2011 | US20110212474 Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells |
| 09/01/2011 | US20110212464 Pacap as a marker for cancer |
| 09/01/2011 | US20110212460 Assay for nitrous oxide neurologic syndrome |
| 09/01/2011 | US20110212459 Novel presenilin associated membrane protein (pamp) and uses thereof |
| 09/01/2011 | US20110212458 Methods for Production of Xylitol in Microorganisms |
| 09/01/2011 | US20110212457 Methods and compositions for determining the pathogenic status of infectious agents |
| 09/01/2011 | US20110212456 K-ras and B-raf mutations and anti-EGFr antibody therapy |
| 09/01/2011 | US20110212455 Method of screening material for improving skin functions |
| 09/01/2011 | US20110212454 Assay for Telomerase Activity |
| 09/01/2011 | US20110212453 Assay card for sample acquisition, treatment and reaction |
| 09/01/2011 | US20110212452 Method for preparative production of long nucleic acids by pcr |
| 09/01/2011 | US20110212451 Rna detection method |
| 09/01/2011 | US20110212450 Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212448 Gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 09/01/2011 | US20110212447 Method of Using FOXO3A Polymorphisms and Haplotypes to Predict and Promote Healthy Aging and Longevity |
| 09/01/2011 | US20110212446 Fast pcr for str genotyping |
| 09/01/2011 | US20110212445 Swi5 gene as a diagnostic target for the identification of fungal and yeast species |
| 09/01/2011 | US20110212444 Use of methylation status of mint loci and tumor related genes as a marker for melanoma and breast cancer |
| 09/01/2011 | US20110212443 Method for determining the specific growth rate of distinct microbial populations in a non-homogeneous system |
| 09/01/2011 | US20110212442 Universal nucleic acid probe set and method for utilization thereof |
| 09/01/2011 | US20110212441 Methods and Systems for Inferring Bovine Traits |
| 09/01/2011 | US20110212440 Cell sorting device |
| 09/01/2011 | US20110212439 Hla alleles associated with adverse drug reactions and methods for detecting such |
| 09/01/2011 | US20110212438 Kits and Devices for Performing Methods of Detecting Viability-Associated Molecules |
| 09/01/2011 | US20110212437 Single molecule sequencing with two distinct chemistry steps |
| 09/01/2011 | US20110212436 Molecular redundant sequencing |
| 09/01/2011 | US20110212435 Antimicrobial Compounds |
| 09/01/2011 | US20110212434 Novel hiv-based recombinant viral clones and use thereof in analytical methods |
| 09/01/2011 | US20110212432 Separation of blood cells from a blood sample |
| 09/01/2011 | US20110212230 Evaluating bacterial lethality of containerized food production |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212111 MHC II Associated Protein and Uses Thereof |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212101 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212075 Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders |
| 09/01/2011 | US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction |
| 09/01/2011 | US20110212069 Modulation of Microglia Activation |
| 09/01/2011 | US20110212061 Mesoderm and Definitive Endoderm Cell Populations |
| 09/01/2011 | US20110212047 Polymer Therapy for the Treatment of Chronic Microvascular Diseases |